Deep Longevity Launched a Free Self-help Application, FuturSelf, Powered by Research Conducted with Harvard Medical School, on Optimizing Future Well-being with Artificial Intelligence
HONG KONG, June 21, 2022 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announce its collaboration with Dr. Nancy Etcoff of Harvard Medical School. Dr. Etcoff is widely recognized...
Cathay Biotech to showcase thermoplastic bio-based composite materials (bio-PPA CFRT) at 2025 JEC World
PARIS, Feb. 11, 2025 /PRNewswire/ -- The global composite materials industry's attention will soon be focused on the JEC World 2025 exhibition, which will be held from March 4th to 6th at the Paris Nord Villepinte Exhibition Centre in France. At this highly anticipated event, Cathay Biotech will showcase its breakthrough application achievements and solutions of thermoplastic bio-based composite materials...
Docquity and AstraZeneca’s Patient Support Program Educates Tens of Thousands in Thailand
OAZisCare, digitally powered by DocquityCare, has advanced patient education and adherence for cancer care and RSV vaccines since 2024 The collaboration helps tackle Southeast Asia's healthcare needs, with 85.7% of doctors noting immunization rates could improve with patient support (Docquity Pulse Check) BANGKOK, April 22, 2025 /PRNewswire/ -- Docquity, Southeast...
Immunofoco Earns Spot on Forbes Asia 100 to Watch 2025 List for Leading New Wave in Solid Tumor Cell Therapy
SHANGHAI, Sept. 5, 2025 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company, focused on developing novel cell therapies for solid tumors, has been selected for the prestigious "Forbes Asia 100 to Watch 2025" list. This annual list, compiled by the editors of Forbes Asia, spotlights outstanding small companies and startups across the Asia-Pacific region that are recognized for their innovation...
Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies
Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development. SAN ANTONIO, April 25, 2023 /PRNewswire/ -- Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. Each year, Frost...
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners
Recognizing Roper St. Francis Healthcare, Bon Secours Mercy Health, and Bronson Methodist Hospital for excellence in Physician and Hospital Groups LONDON, Nov. 13, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the 2023 winners of the Clarivate Healthcare Business Insights™ annual Revenue Cycle Awards. Now in its 12th year,...
Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene
BEIJING, April 8, 2022 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that they have reached an agreement with BeiGene (Beijing) Co., Ltd. ("BeiGene") (NASDAQ code: BGNE; Hong Kong Stock Exchange code: 06160; Shanghai Stock Exchange code: 688235) on March 10, for licensing of Biocytogen's fully human antibody RenMab™/RenLite™ mice platform with proprietary intellectual property rights of Biocytogen to develop...
Illuminating ctDNA-MRD: Gene Solutions’ K-CONNECT APAC 2025 Sparks Regional Collaboration in Precision Oncology
DA NANG, Vietnam, May 31, 2025 /PRNewswire/ -- May 9-11, 2025, Gene Solutions, a pioneer in AI-driven precision oncology hosted K-CONNECT APAC 2025, a pivotal summit uniting over 100 distinguished oncologists and molecular biologists from nine Asia-Pacific countries. — This landmark event marked a significant milestone in advancing precision oncology, fostering collaboration, and driving innovation in the fields of circulating tumor...
WATERDROP ANNOUNCES CERTAIN BOARD AND EXECUTIVE CHANGES
BEIJING, March 17, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced the appointment of Mr. Wei Ran as a new director to its board of directors (the "Board") and the resignation of Mr. Yao Hu from the...
Qilian International Holding Group Limited Received Approval for Oxytetracycline API Export to Egypt
JIUQUAN, China, Oct. 13, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that on September 14, 2021, through its subsidiary Gansu Qilianshan Pharmaceutical Co., Ltd. (the "Gansu QLS"), it has received Certificate of a Pharmaceutical Product (the "Export Certificate") from Gansu Province Drug Administration, which approves the export of its Qilian Shan® Oxytetracycline APIs (Active Pharmaceutical Ingredients)...
